文献类型：期刊文献

英文题名：Feasibility of transgastric endoscopic gallbladder-preserving surgery for benign gallbladder diseases (with video)

作者：Zhang, Yu[1,2];Mao, Xin-Li[1,2];Zhou, Xian-Bin[2];You, Ning-Ning[2];Xu, Shi-Wen[2];Zhu, Lin-Hong[3];Ye, Li-Ping[2]

机构：[1]Shaoxing Univ, Sch Med, Taizhou Hosp Zhejiang Prov, Dept Gastroenterol, Linhai 317000, Zhejiang, Peoples R China;[2]Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Gastroenterol, Key Lab Minimally Invas Tech & Rapid Rehabil Dige, 150 Ximen St, Linhai, Zhejiang, Peoples R China;[3]Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Med Adm, Linhai, Peoples R China

年份：2022

卷号：36

期号：4

起止页码：2705

外文期刊名：SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

收录：SCI-EXPANDED(收录号：WOS:000746343900002)、、Scopus(收录号：2-s2.0-85123625818)、WOS

基金：This study was supported by the Major R&D Project of Zhejiang Province (no. 2019C03040) and the Zhejiang Province Bureau of Health (no. 2020KY1030).

语种：英文

外文关键词：Gallbladder stone; Gallbladder polyp; Endoscopic gallbladder-preserving surgery; Natural orifice transluminal endoscopic surgery

外文摘要：Background With the increasing realization of the importance of gallbladder function, choledochoscopic gallbladder-preserving surgery has been advocated for benign gallbladder diseases. However, limited information is available regarding the use of endoscopic gallbladder-preserving surgery (EGPS) for patients with benign gallbladder diseases. The aim of this study was to evaluate the feasibility of EGPS for benign gallbladder diseases. Methods Between June 2020 and January 2021, 22 patients with gallbladder stones and/or gallbladder polyps were treated with EGPS. The main outcome measures included the rate of complications, residual gallbladder stones, and gallbladder stone recurrence. Results In this study, transgastric EGPS was successfully performed in 22 patients (13 female, 9 male) with benign gallbladder diseases, and included 8 cases of multiple gallstones, 4 cases of gallbladder polyps with gallstones, 6 cases of multiple gallbladder polyps, 2 cases of single gallstone, and 2 case of singe gallbladder polyp. The median time of transgastric EGPS was 118 min. During hospitalization, 4 patients suffered localized peritonitis (4/22, 18.2%), and these patients successfully recovered after conservative medical treatment. None of the patients experienced massive bleeding, delayed bleeding, diffuse peritonitis, or any other serious complications. During the median follow-up of 4 months, 1 patient suffered residual gallstone, while no gallstone recurrence or deaths related to transgastric EGPS occurred in any patients. Conclusions Transgastric EGPS appears to be a feasible treatment method in selected patients with benign gallbladder diseases. However, as it is a new technique, further studies are needed to explore the long-term effectiveness of transgastric EGPS.